Volume 26 (2023)
Volume 25 (2022)
Volume 24 (2021)
Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
Lepromatous leprosy with an atypical psoriasiform presentation mimicking psoriasis: a case report

Bhagyashree B Supekar; Vrutika H Shah; Jayesh Mukhi; Rajesh P Singh

Volume 26, Issue 1 , March 2023, , Pages 43-48

https://doi.org/10.22034/ijd.2021.254920.1254

Abstract
  Leprosy, just like syphilis, has become a great imitator with its various atypical and unusual presentations. It presents in many diverse ways and can be confused with many infectious and non-infectious forms.It is often misdiagnosed as common disorders like psoriasis, pyoderma, angioedema, pre-vitiligo, ...  Read More

A man with hypoesthetic skin lesions: a case report of immune reconstitution inflammatory syndrome

Siti Nurhidayah Pazil; Maryam Mohd Zulkifli; Rosediani Muhamad; Loh Ken Chen

Volume 24, Issue 3 , September 2021, , Pages 234-237

https://doi.org/10.22034/ijd.2021.136582

Abstract
  The use of highly active antiretroviral therapy (HAART) has prevented opportunistic infections that often lead to death in HIV-positive patients. However, in resource-poor countries, HAART is only initiated at an advanced stage. This could lead to the antiretroviral-induced immune reconstitution syndrome ...  Read More

Exploring the efficacy of the Mycobacterium indicus pranii (MIP) vaccine in reducing the impact of the ongoing COVID-19 pandemic

Santoshdev Rathod; Raju G Chaudhary; Tarun Narang

Volume 23, Suppl.1(COVID-19) , 2020, , Pages 67-70

https://doi.org/10.22034/ijd.2020.114853

Abstract
  Vaccine makers are racing to develop COVID-19 vaccines and have advanced ten candidates into clinical trials. However, vaccine development is typically a lengthy process. A number of immuneresponse modifiers have also been explored for their efficacy in the management of COVID-19. In this ...  Read More

Dapsone and its uses in dermatology

H Tabatabai; M Heydari Seradj

Volume 4, Issue 1 , 2000, , Pages 36-50

Abstract
  Dapsone first came into medicine as an antibacterial agent but was found to be less effective than other sulfonamides. Likewise its activity against tuberculosis was disappointing. Nevertheless, it has been the main stay in the treatment of leprosy. It also has some action against malaria and other parasites. ...  Read More

Evaluation of the knowledge of personnel employed in health system network of Gilan province on Leprosy

J Gholchye; H Shojaei Tehrani

Volume 3, Issue 1 , 1999, , Pages 5-10

Abstract
  Background: Leprosy is a chronic infectious disease endemic in some areas of Gilan province. Objective: To evaluate the knowledge of the personnel employed in Health System Network (Including Behvarzes, Kardans and physicians) on leprosy. Materials and Methods: Questionnaires consisting of 14 multiple ...  Read More

Pure neural Leprosy: A case report

H Tabatabai

Volume 3, Issue 1 , 1999, , Pages 52-57

Abstract
  Leprosy is a chronic infectious disease endemic in Iran that mainly involves skin and peripheral nerves. Leprosy has several clinical forms. One of them is “Pure neural leprosy”. The diagnosis of this form is delayed due to lack of clinical signs in other tissues and can lead to permanent ...  Read More